Three Filipino healthcare tech platforms below the Ayala Company, one of many largest conglomerates within the Philippines, will probably be built-in to kind one well being superapp.
Based mostly on a inventory alternate disclosure, KonsultaMD, HealthNow, and AIDE will probably be consolidated below KonsultaMD, which is anticipated to be launched by the primary quarter of 2023.
KonsultaMD is a telehealth app run by company enterprise builder 917Ventures, which additionally developed the healthcare app HealthNow along with Ayala Corp.’s healthcare arm AC Well being. AIDE is a just lately acquired medical care app by HealthNow.
Collectively, these apps have a mixed person base of over two million.
WHY IT MATTERS
The well being superapp will mix teleconsultations supplied by KonsultaMD, medication supply companies by HealthNOW, and AIDE’s laboratory exams and residential care.
KonsultaMD is the dominant telehealth participant within the Philippines with over 1,000,000 members and a retail community of greater than 50,000 shops. HealthNow and AIDE reportedly have grown their base to over a million registered customers as properly.
“Consultations are on the high of the funnel. Consultations generate prescriptions which in flip generate lab requests. Now, we will fulfil all of those. We’re a one-stop store for all of your well being wants,” stated Cholo Tagaysay, incoming CEO of the consolidated entity.
With an identical goal of increasing entry to high quality healthcare, Filipino conglomerate Equicom Group and Singapore-headquartered DoctorAnywhere partnered final 12 months to arrange a telemedicine three way partnership within the Philippines.
In different information, Metro Pacific Well being Tech Company just lately tapped Active8me, a Singapore-based digital wellness firm, so as to add personalised day by day health, diet and wellness programmes to its cellular well being app mWell.
ON THE RECORD
The relaunching of KonsultaMD as a superapp will place AC Heath ready to offer “much-needed entry to high quality healthcare companies and medicines throughout the nation, accelerating our aim of touching the lives of 1 in 5 Filipinos by 2030,” CEO and President Paolo Borromeo commented